Vaccine Manufacturers Aim To Ramp Up Distribution

Pfizer plans to ramp up vaccine deliveries despite initial delays, aiming for 300 million doses by July. Manufacturing challenges, particularly with raw materials, have been addressed. Pfizer and Moderna have FDA-approved vaccines, while Johnson & Johnson awaits approval for its single-shot vaccine.

What new insight or understanding did you gain from this video?